Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts
Karrie Kwan Ki Ko, Hatairat Yingtaweesittikul, Thuan Tong Tan, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
Chrispin Chaguza, Anne M. Hahn, Mary E. Petrone, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100943-100943
Open Access | Times Cited: 74
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 51
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial
Matthew G. Johnson, Julie Strizki, Michelle Brown, et al.
Infection (2023) Vol. 51, Iss. 5, pp. 1273-1284
Open Access | Times Cited: 28
SARS-CoV-2 evolution during prolonged infection in immunocompromised patients
Andrew D. Marques, Jevon Graham-Wooten, Ayannah S. Fitzgerald, et al.
mBio (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 10
SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs
Sho Iketani, David D. Ho
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 632-657
Open Access | Times Cited: 7
Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review
David Hettle, Stephanie Hutchings, Peter Muir, et al.
Clinical Infection in Practice (2022) Vol. 16, pp. 100210-100210
Open Access | Times Cited: 33
Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
Chrispin Chaguza, Anne M. Hahn, Mary E. Petrone, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 32
Evolution of SARS-CoV-2 in white-tailed deer in Pennsylvania 2021–2024
Andrew D. Marques, Matthew Hogenauer, Natalie Bauer, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012883-e1012883
Open Access
Single Monoclonal Antibodies Should Not Be Used for Coronavirus Disease 2019 Therapy: A Call for Antiviral Stewardship
Arturo Casadevall, Daniele Focosi, Liise-anne Pirofski, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 6, pp. 1404-1407
Closed Access | Times Cited: 4
Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection
Sung Hee Ko, Pierce Radecki, Frida Belinky, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
SARS‐CoV‐2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment
Akram Sadat Ahmadi, Sevrin Zadheidar, Kaveh Sadeghi, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 11
Overview of Nucleocapsid-Targeting Vaccines against COVID-19
Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko
Vaccines (2023) Vol. 11, Iss. 12, pp. 1810-1810
Open Access | Times Cited: 10
Relapsing COVID-19 infection as a manifestation of Good syndrome: a case report and literature review
Liang En Wee, Jing Yuan Tan, Lynette Lin Ean Oon, et al.
International Journal of Infectious Diseases (2023) Vol. 129, pp. 236-239
Open Access | Times Cited: 8
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Detection of viable SARS-CoV-2 in deep respiratory specimens despite negative nasopharyngeal SARS-CoV-2 RT-PCR: Occult COVID-19 as an unsuspected cause of pulmonary infiltrates in immunocompromised patients
Liang En Wee, Jing Yuan Tan, Karrie Kwan Ki Ko, et al.
IDCases (2022) Vol. 30, pp. e01611-e01611
Open Access | Times Cited: 12
Whole‐genome single molecule real‐time sequencing of SARS‐CoV‐2 Omicron
Florence Nicot, Pauline Trémeaux, Justine Latour, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 7
Challenges and Progress in Designing Broad-Spectrum Vaccines Against Rapidly Mutating Viruses
Rishi Bedi, Nicholas Bayless, Jacob Glanville
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 419-441
Open Access | Times Cited: 7
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 2
SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin’s Lymphoma
Rodrigo Villaseñor-Echavarri, Laura Gómez-Romero, Alexandra Martin‐Onraët, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 377-377
Open Access | Times Cited: 5
The Effect of Select SARS-CoV-2 N-Linked Glycan and Variant of Concern Spike Protein Mutations on C-Type Lectin-Receptor-Mediated Infection
Arjan Bains, Wenyan Guan, Patricia J. LiWang
Viruses (2023) Vol. 15, Iss. 9, pp. 1901-1901
Open Access | Times Cited: 5
The origins of new SARS-COV-2 variants in immunocompromised individuals
Anna C. Riddell, Teresa Cutiño‐Moguel
Current Opinion in HIV and AIDS (2023)
Closed Access | Times Cited: 4
Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study
Cléa Melenotte, Nathalie Chavarot, Anne-Sophie L’Honneur, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 2
Open Access | Times Cited: 1
Within-Host Influenza Viral Diversity in the Pediatric Population as a Function of Age, Vaccine and Health Status
Ashley Sobel Leonard, Lydia Mendoza, Alexander McFarland, et al.
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Introducing a framework for within-host dynamics and mutations modelling of H5N1 influenza infection in humans
Daniel P Higgins, Joshua Looker, Robert Sunnucks, et al.
(2024)
Open Access
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection
Michael Schoefbaenker, Theresa Günther, Eva U. Lorentzen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012624-e1012624
Open Access
Page 1 - Next Page

Scroll to top